Factors influencing antiretroviral adherence and virological outcomes in people living with HIV in the Highlands of Papua New Guinea

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Gare, Janet ^a,b,c   Kelly Hanku, Angela ^a,d   Ryan, Claire E ^b   David, Matthew ^a   Kaima, Petronia ^e   Imara, Ulato ^f   Lote, Namarola ^a   Crowe, Suzanne M ^b,c   Hearps, Anna C ^b,c  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b BURNET INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e HIV STI Highlands Region National Department of Health   (Papua New Guinea)

^f Goroka General Hospital   (Papua New Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADULT; AMNESIA; ARTICLE; BACTERIAL INFECTION; BLOATING; CD4 LYMPHOCYTE COUNT; CONDOM USE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DRUG TREATMENT FAILURE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE; MAJOR CLINICAL STUDY; MALARIA; MALE; MIDDLE AGED; MIXED INFECTION; NAUSEA; OUTCOME ASSESSMENT; PAPUA NEW GUINEA; PATIENT COMPLIANCE; PNEUMONIA; PREDICTOR VARIABLE; RELIGION; SEXUAL ABSTINENCE; SEXUALLY TRANSMITTED DISEASE; SKIN TINGLING; SPIRITUAL HEALING; TUBERCULOSIS; TYPHOID FEVER; VIRUS TRANSMISSION; ALTITUDE; ATTITUDE TO HEALTH; DRUG EFFECTS; EPIDEMICS; GEOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; MEDICATION COMPLIANCE; PHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; VIROLOGY; VIRUS LOAD;

ADULT; ALTITUDE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; EPIDEMICS; FEMALE; GEOGRAPHY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAPUA NEW GUINEA; SOCIOECONOMIC FACTORS; SURVEYS AND QUESTIONNAIRES; VIRAL LOAD;

EID: 84941897229     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134918     Document Type: Article

References (39)

1. HIV/AIDS Fact Sheets (2014). Port Moresby, Papua New Guinea: National AIDS Council Secretariat and National Department of Health.
2. William J, McBride (2005) HIV/AIDS in Papua New Guinea: An unfolding Disaster? Emergency Medicine Australasia 17: 304-306. PMID: 16091091
3. Kaldor JM LM, Henderson K (February 2006) Impacts of HIV/AIDS 2003-2025 in PNG, Indonesia, and East Timor: Final Report of HIV Epidemiological Modelling and Impact Study. Canberra Australia: AusAID.
4. Kelly A, Kupul M, Man N, Nosi S, Lote N, Rawstorne P, et al. (2011) Askim na Save (Ask and Understand): People who sell and exchange sex in Port Moresby. Sydney, Australia: Papua New Guinea Institute of Medical Research and the University of New South Wales. 1-36 p.
5. STI, HIV, and AIDS Second Quarter Surveillance Report (April-June, 2010). Port Moresby, Papua New Guinea: National Department of Health.
6. Maibani G, Ryan C, Lote N, Edward G, Gare J, Kaldor J, et al. (2011) Papua New Guinea-Australia Sexual Health Improvement Program (PASHIP): Report on Baseline Survey. Goroka: Papua New Guinea Institute of Medical Research. 1-56 p.
7. Global AIDS Report (2012). Port Moresby, Papua New Guinea: National AIDS Council Secretariat.
8. Kelly-Hanku A, Rawstorne P, Kupul M, Worth H, Shih P, Man WY (2014) Anal sex, vaginal sex and HIV risk among female sex workers in Papua New Guinea. AIDS Behav 18: 573-582. doi: 10.1007/s10461-013-0624-8 PMID: 24264727
9. Kelly-Hanku A, Vallely A, Man WY, Wilson D, Law G, Gray R (2013) A systematic review of heterosexual anal intercourse and its role in the transmission of HIV and other sexually transmitted infections in Papua New Guinea. BMC Public Health 13: 1108. doi: 10.1186/1471-2458-13-1108 PMID: 24289271
10. Papua New Guinea: 2013 HIV estimates. Port Moresby: National AIDS Council Secretariat.
11. Malagun M, Nano G, Chevallier C, Opina R, Sawiya G, Kivavia J, et al. (2014) Multisite Evaluation of Point of Care CD4 Testing in Papua New Guinea. PLoS One 9: e112173. doi: 10.1371/journal.pone.0112173 PMID: 25426710
12. Li JZ, Gallien S, Ribaudo H, Heisey A, Bangsberg DR, Kuritzkes DR (2014) Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia. AIDS 28: 181-186. doi: 10.1097/QAD.0000000000000123 PMID: 24361679
13. Nilsson Schonnesson L, Diamond PM, Ross MW, Williams M, Bratt G (2006) Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care 18: 407-414. PMID: 16809121
14. Portelli MS, Tenni B, Kounnavong S, Chanthivilay P (2012) Barriers to and Facilitators of Adherence to Antiretroviral Therapy Among People Living With HIV in Lao PDR: A Qualitative Study. Asia Pac J Public Health.
15. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. (2003) Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 34: 281-288. PMID: 14600572
16. Kelly A, Mek A, Frankland A, Akunai F, Kepa B, Kupul M, et al. (2011) Moresby food isn't good: food security, nutritional information and adherence to antiretroviral therapy in Papua New Guinea. P N G Med J 54: 23-34. PMID: 23763036
17. Daoni E, Kitur U, Parunga A, Ndenzako F, Lloyd A, Yu D (2012) Experience in Piloting HIV Drug Resistance Early Warning Indicators to Improve the Antiretroviral Program in Papua New Guinea. Clin Infect Dis 54: S303-S305. doi: 10.1093/cid/cir994 PMID: 22544192
18. Larson EC, Hathaway LB, Lamb JG, Pond CD, Rai PP, Matainaho TK, et al. (2014) Interactions of Papua New Guinea medicinal plant extracts with antiretroviral therapy. J Ethnopharmacol 155: 1433-1440. doi: 10.1016/j.jep.2014.07.023 PMID: 25138353
19. Kelly A, Worth H, Man N, Nosi S, Emori R, Mek A, et al. (2010) Barriers and facilitators for adherence to antiretroviral therapy in Papua New Guinea. Curr HIV Res 8: 630-637. PMID: 20946092
20. Gare J, Ryan CE, David M, Timbi D, Kaima P, Kombati Z, et al. (2014) Presence of HIV drug resistance in antiretroviral therapy-naive and-experienced patients from Papua New Guinea. J Antimicrob Chemother 69: 2183-2186. doi: 10.1093/jac/dku089 PMID: 24722838
21. Greengrass VL, Plate MM, Steele PM, Denholm JT, Cherry CL, Morris LM, et al. (2009) Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring. J Clin Microbiol 47: 3011-3013. doi: 10.1128/JCM.00805-09 PMID: 19605583
22. Tadios Y, Davey G (2006) Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Ethiop Med J 44: 237-244. PMID: 17447389
23. Tiyou A, Belachew T, Alemseged F, Biadgilign S (2010) Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia. AIDS Res Ther 7: 39. doi: 10.1186/1742-6405-7-39 PMID: 21034506
24. Obirikorang C, Selleh PK, Abledu JK, Fofie CO (2013) Predictors of Adherence to Antiretroviral Therapy among HIV/AIDS Patients in the Upper West Region of Ghana. ISRN AIDS 2013: 873939. doi: 10.1155/2013/873939 PMID: 24386593
25. Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K (2008) Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health 8: 265. doi: 10.1186/1471-2458-8-265 PMID: 18667066
26. Berg KM, Arnsten JH (2006) Practical and Conceptual Challenges in Measuring Antiretroviral Adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes 43: S79-S87 10.1097/1001.qai.0000248337.0000297814.0000248366. PMID: 17133207
27. Wang H, He G, Li X, Yang A, Chen X, Fennie KP, et al. (2008) Self-Reported adherence to antiretroviral treatment among HIV-infected people in Central China. AIDS Patient Care STDS 22: 71-80. PMID: 18095837
28. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. (2006) Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3: e438. PMID: 17121449
29. Gill CJ, Sabin LL, Hamer DH, Keyi X, Jianbo Z, Li T, et al. (2010) Importance of Dose Timing to Achieving Undetectable Viral Loads. AIDS and Behavior 14: 785-793. doi: 10.1007/s10461-009-9555-9 PMID: 19353263
30. Rodrigues R, Shet A, Antony J, Sidney K, Arumugam K, Krishnamurthy S, et al. (2012) Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India. PLoS One 7: e40723. doi: 10.1371/journal.pone.0040723 PMID: 22952574
31. Tumwine C, Neema S, Wagner G (2012) Reasons Why High Religiosity Can Co-exist with and Precipitate Discontinuation of Anti-retroviral Therapy among Different HIV Clients in Uganda: An Exploratory Study. Religions (Basel) 3: 817-832.
32. Liam C (2014) Faith healing replacing medication for HIV in PNG.
33. Kisenyi RN, Muliira JK, Ayebare E (2013) Religiosity and adherence to antiretroviral therapy among patients attending a public hospital-based HIV/AIDS clinic in Uganda. J Relig Health 52: 307-317. doi: 10.1007/s10943-011-9473-9 PMID: 21360222
34. Wanyama J, Castelnuovo B, Wandera B, Mwebaze P, Kambugu A, Bangsberg DR, et al. (2007) Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. AIDS 21: 1486-1487. PMID: 17589198
35. Kelly-Hanku A, Aggleton P, Shih P (2014) 'We call it a virus but I want to say it's the devil inside': Redemption, moral reform and relationships with God among people living with HIV in Papua New Guinea. Soc Sci Med 119C: 106-113.
36. Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, et al. (2006) Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 41: 385-392. PMID: 16540942
37. Wouters E, Van Damme W, Van Loon F, van Rensburg D, Meulemans H (2009) Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. Soc Sci Med 69: 1177-1185. doi: 10.1016/j.socscimed.2009.07.034 PMID: 19692165
38. Mosha F, Ledwaba J, Ndugulile F, Ng'ang'a Z, Nsubuga P, Morris L, et al. (2014) Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania. J Infect Dev Ctries 8: 845-852. doi: 10.3855/jidc.3879 PMID: 25022294
39. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. (2000) Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 12: 255-266. PMID: 10928201